[PDF] from biomedcentral.comJ Maroco, D Silva, A Rodrigues… - BMC Research …, 2011 - biomedcentral.com ... goingdementingdisorde rlike A lzheimer ' sdisease . I tispossibletoidentify peoplewithcognitiveco mplaintswho ... neuropsychologicaltes tingisakeyelementinth ediagnosticprocedures [ 4 ] . R ecently , ithasbecomepossibleto identifythetraces , orbiomarkers , of A lzheimer ' s ...
SJ Texel… - Antioxidants & Redox Signaling, 2011 - liebertonline.com ... A lzheimer's Disease (AD) was first described as a relatively rare disorder by Alois Alzheimer in 1906 and now, 1 century later, nearly 5 million Americans are living with AD and the numbers are rapidly rising as baby boomers enter the AD danger zone of >65 years of age. ... Cited by 1 - Related articles - All 2 versions
M Müller, KH Cheung… - Antioxidants & Redox …, 2011 - liebertonline.com ... A lzheimer's disease (AD) is a common form of dementia involving slowly developing and ultimately fatal neurodegeneration. Age is the main risk factor but the major molecular mechanisms are still unclear. A hallmark feature ... Cited by 6 - Related articles - All 3 versions
KA Treiber, MC Carlson… - The Journals …, 2011 - psychsocgerontology.oxfordjournals. … ... ALZHEIMER'S disease (AD) is a neurodegenerative disorder that leads to cognitive and functional deterioration. Despite its progressive course, there is considerable variability in the rates of cognitive and functional decline ... Related articles - All 3 versions
[PDF] from annabolteus.comAC Paula-Lima, T Adasme, C SanMartín… - … & Redox Signaling, 2011 - liebertonline.com ... A lzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by progressive memory loss that leads inevitably to severe dementia. Numerous reports have linked the pathogenesis of AD, the most frequent ... Cited by 5 - Related articles - All 4 versions